#$%^&*AU2018200323A120180201.pdf#####ll: dar Interwovn NRPortbl DCC DAR 12171789_l.docx-25 112016 Abstract The present invention relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a mTOR inhibitor or a pharmaceutically acceptable salt thereof.